These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 18450952)
1. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952 [TBL] [Abstract][Full Text] [Related]
2. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells. Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498 [TBL] [Abstract][Full Text] [Related]
3. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C. Bougen NM; Yang T; Chen H; Lobie PE; Perry JK Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106 [TBL] [Abstract][Full Text] [Related]
4. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma. Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274 [TBL] [Abstract][Full Text] [Related]
5. STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. Tang JZ; Kong XJ; Banerjee A; Muniraj N; Pandey V; Steiner M; Perry JK; Zhu T; Liu DX; Lobie PE Endocrinology; 2010 Sep; 151(9):4133-45. PubMed ID: 20668024 [TBL] [Abstract][Full Text] [Related]
6. Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma. Kong X; Wu W; Yuan Y; Pandey V; Wu Z; Lu X; Zhang W; Chen Y; Wu M; Zhang M; Li G; Tan S; Qian P; Perry JK; Lobie PE; Zhu T Oncotarget; 2016 May; 7(20):29465-79. PubMed ID: 27102295 [TBL] [Abstract][Full Text] [Related]
7. Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy. Ding K; Yuan Y; Chong QY; Yang Y; Li R; Li X; Kong X; Qian P; Xiong Z; Pandey V; Ma L; Wu Z; Lobie PE; Zhu T Endocrinology; 2017 Jun; 158(6):1595-1611. PubMed ID: 28204229 [TBL] [Abstract][Full Text] [Related]
8. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells. Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963 [TBL] [Abstract][Full Text] [Related]
9. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression. Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312 [TBL] [Abstract][Full Text] [Related]
10. Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent. Kaulsay KK; Mertani HC; Lee KO; Lobie PE Endocrinology; 2000 Apr; 141(4):1571-84. PubMed ID: 10746665 [TBL] [Abstract][Full Text] [Related]
11. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849 [TBL] [Abstract][Full Text] [Related]
12. Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma. Wang JJ; Chong QY; Sun XB; You ML; Pandey V; Chen YJ; Zhuang QS; Liu DX; Ma L; Wu ZS; Zhu T; Lobie PE Oncotarget; 2017 Nov; 8(61):103900-103918. PubMed ID: 29262609 [TBL] [Abstract][Full Text] [Related]
13. Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells. Chiesa J; Ferrer C; Arnould C; Vouyovitch CM; Diaz JJ; Gonzalez S; Mares P; Morel G; Wu ZS; Zhu T; Lobie PE; Mertani HC J Clin Endocrinol Metab; 2011 Sep; 96(9):E1418-26. PubMed ID: 21733992 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model. Evans A; Jamieson SM; Liu DX; Wilson WR; Perry JK Cancer Lett; 2016 Aug; 379(1):117-23. PubMed ID: 27241667 [TBL] [Abstract][Full Text] [Related]
15. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma. Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525 [TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of autocrine/paracrine effects of human growth hormone in human mammary carcinoma cells. Vouyovitch CM; Vidal L; Borges S; Raccurt M; Arnould C; Chiesa J; Lobie PE; Lachuer J; Mertani HC Adv Exp Med Biol; 2008; 617():493-500. PubMed ID: 18497074 [TBL] [Abstract][Full Text] [Related]
17. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545 [TBL] [Abstract][Full Text] [Related]
18. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143 [TBL] [Abstract][Full Text] [Related]
19. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519 [TBL] [Abstract][Full Text] [Related]
20. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]